Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
The Journal of Urology|May 31, 2016
SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy CohortMichael H Johnson, Ashley E Ross, Mohammed Alshalalfa, et al.
European Urology|August 2, 2016
Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical ProstatectomyJeffrey J Tosoian, Fawaz Almutairi, Carlos L Morais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2018
MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic DiseaseRaj R Bhanvadia, Calvin VanOpstall, Hannah Brechka, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasAntoun Toubaji, Roula Albadine, Alan K Meeker, et al.
The Journal of Pathology. Clinical Research|July 14, 2022
The prostate tissue-based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomyChristopher M Heaphy, Corinne E Joshu, John R Barber, et al.
Plos One|January 6, 2016
Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical ProstatectomySheila F Faraj, Stephania M Bezerra, Kasra Yousefi, et al.
BMC Cancer|February 15, 2024
Rate of benign histology after resection of suspected renal cell carcinoma: multicenter comparison between Korea and the United StatesChang Wook Jeong, Jang Hee Han, Seok Soo Byun, et al.
Medical Oncology (Northwood, London, England)|April 28, 2022
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancerDiane K Reyes, Bruce J Trock, Phuoc T Tran, et al.
Cancer|November 14, 2018
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centersDebasish Sundi, Jeffrey J Tosoian, Yaw A Nyame, et al.
European Urology|May 24, 2020
Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical TrialHiten D Patel, Farzana A Faisal, Bruce J Trock, et al.
Pageof 19